Authors/Disclosures
|
Michael D. Geschwind, MD, PhD, FAAN
(UCSF)
|
Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc.. |
|
Corey McMillan, PhD
(University of Pennsylvania)
|
Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH. |
|
Amy Kuo
|
No disclosure on file |
|
Benjamin Raudabaugh
(UCSF)
|
No disclosure on file |
|
Aissatou Haman
|
No disclosure on file |
|
Gillian Devereux
|
No disclosure on file |
|
|
No disclosure on file |
|
Charles Torres-Chae
(University of California San Francisco)
|
No disclosure on file |
|
Julie N. Thai
|
No disclosure on file |
|
Katherine Wong, MD
(University of Southern California)
|
Dr. Wong has nothing to disclose. |
|
Stanley B. Prusiner, MD, FAAN
(Univ of Calif at San Francisco)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Bruce L. Miller, MD, FAAN
(University of California, San Francisco)
|
Dr. Miller has nothing to disclose. |